» Articles » PMID: 32824428

Integrative Management of Metabolic Syndrome in Youth Prescribed Second-Generation Antipsychotics

Overview
Journal Med Sci (Basel)
Specialty General Medicine
Date 2020 Aug 23
PMID 32824428
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Weight gain and metabolic syndrome are common side effects of second-generation antipsychotics and carry significant health consequences both in childhood and into adulthood. This review highlights evidence-based, non-pharmacologic interventions to assist in the management of these side effects. Such intervention categories include dietary, physical activity, sleep, stress management, and nutritional supplementation. Interventions with the highest quality evidence include increasing the consumption of fruits, vegetables, and whole grains, increasing physical activity, improving sleep, and fish oil supplementation. We suggest that clinicians work with patients on managing metabolic side effects in a patient-centered way, incorporating principles of motivational interviewing, to reduce the risk of metabolic syndrome.

Citing Articles

The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children.

Libowitz M, Nurmi E Front Psychiatry. 2021; 12:623681.

PMID: 33776816 PMC: 7994286. DOI: 10.3389/fpsyt.2021.623681.

References
1.
Balk E, Tatsioni A, Lichtenstein A, Lau J, Pittas A . Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care. 2007; 30(8):2154-63. DOI: 10.2337/dc06-0996. View

2.
Siriwat R, Wang L, Shah V, Mehra R, Ibrahim S . Obstructive sleep apnea and insulin resistance in children with obesity. J Clin Sleep Med. 2020; 16(7):1081-1090. PMC: 7954072. DOI: 10.5664/jcsm.8414. View

3.
Park S, Cervesi C, Galling B, Molteni S, Walyzada F, Ameis S . Antipsychotic Use Trends in Youth With Autism Spectrum Disorder and/or Intellectual Disability: A Meta-Analysis. J Am Acad Child Adolesc Psychiatry. 2016; 55(6):456-468.e4. DOI: 10.1016/j.jaac.2016.03.012. View

4.
Mortera R, Bains Y, Gugliucci A . Fructose at the crossroads of the metabolic syndrome and obesity epidemics. Front Biosci (Landmark Ed). 2018; 24(2):186-211. DOI: 10.2741/4713. View

5.
Sarris J, Mischoulon D, Schweitzer I . Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. J Clin Psychiatry. 2011; 73(1):81-6. DOI: 10.4088/JCP.10r06710. View